Drugmakers Eager to Diversify Suppliers Help A10 Soar

In 1987, Leah Brown lost an uncle to AIDS. His death left Brown, then a law student at Rutgers University, frustrated and deeply disappointed that drugs to treat the deadly disease were not yet available. The stinging memory of losing her “very best friend” stuck with Brown, inspiring the contract research company she founded 18 years later, in 2005, to assist in medical research and the development of new drugs.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.